您的位置: 首页 > 农业专利 > 详情页

N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
专利权人:
Janssen Alzheimer Immunotherapy
发明人:
Schenk, Dale B,Bard, Frédérique,Vasquez, Nicki J,Yednock, Ted
申请号:
NO20015773
公开号:
NO337301B1
申请日:
2001.11.27
申请国别(地区):
NO
年份:
2016
代理人:
摘要:
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A² in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A² and antibodies binding to the same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充